Navigation Links
Global Genetic Testing Market Analysis
Date:8/18/2011

NEW YORK, Aug. 18, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Genetic Testing Market Analysis

http://www.reportlinker.com/p0588171/Global-Genetic-Testing-Market-Analysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Genomics

In a rapidly growing molecular diagnostics market, genetic testing represents a highly attractive segment. Genetic testing is a form of medical test that recognizes alteration in chromosomes, genes, or proteins. Most of the time, testing is used to find changes that are associated with inherited disorders. The results of a genetic test can confirm or rule out a suspected genetic condition or help determine a person's chance of developing or passing on a genetic disorder. Several hundred genetic tests are currently in use, and more are being developed.

With the significant increase in the number of available tests, the genetic testing market is witnessing a strong growth pattern. According to our latest report, "Global Genetic Testing Market Analysis", the global genetic testing sector was worth around US$ 1.5 Billion in 2010 that corresponds to a share of approximately 15% in the total molecular diagnostics market. The market is further likely to grow at the rate of around 26% during 2012-2015 to reach around US$ 4 Billion. Factors contributing to this growth include increasing demand of newborn screening, high incidences of Alzheimer disease, breast cancer, colorectal cancer, diabetes etc, and research innovations.

Controversies over the splendid growth of DTC genetic testing have attracted lots of opinions and views on the selling of DNA-based tests directly to consumers. With the FDA intervention, the subject has become of more significance and it would be interesting to see whether new regulations do come in or not. The report, in this context, has presented an effective insight on the current developments in DTC genetic tests.

The report "Global Genetic Testing Market Analysis", covers almost all aspects of the global genetic testing market and provides reliable statistics on current market size and other areas. The report focuses on key regions to illustrate the state of genetic testing market & developments as these countries are witnessing improved private sector activities. Moreover, the availability of gene tests for key diseases has been discussed in a prudent manner. Recent developments with respect to product launches and strategic acquisitions have also been covered. Overall, the report is meant to provide a worth insight into the genetic testing market that would help the client to get acquainted with all the necessary information.

1. Analyst View

2. Research Methodology

3. Introduction to Genetic Testing

4. Global Genetic Testing Market Overview

4.1 Market Outlook

4.2 DTC Genetic Testing

5. Disease Wise Analysis

5.1 Alzheimer's Disease

5.2 Cystic Fibrosis

5.3 Cancer

6. Country Level Analysis

6.1 US

6.2 Europe

6.3 Japan

6.4 Korea

7. Industry Developments

7.1 Key Product Launches

7.2 Key Strategic Acquisitions & Agreements

8. Regulatory Landscape

9. Competitive Assessment

9.1 Abbott Laboratories

9.2 Qiagen N.V.

9.3 bioMerieux SA

9.4 Hoffmann-La Roche Ltd

9.5 Quest Diagnostics

9.6 Myriad Genetics

List of Figures:

Figure 4-1: Molecular Diagnostics Market (Billion US$), 2008-2011

Figure 4-2: Genetic Testing Market (Billion US$), 2008-2011

Figure 4-3: Forecast for Molecular Diagnostics Market (Billion US$), 2012-2015

Figure 4-4: Forecast for Genetic Testing Market (Billion US$), 2012-2015

Figure 4-5: Number of Companies in Biochemical DTC Genetic Testing Segment (2007-2010)

Figure 4-6: Number of DTC Genetic Testing Companies by Country

Figure 6-1: Number of Laboratories and Diseases for Genetic Testing (1993-2010)

Figure 6-2: US - Share of Diagnostics Testing in Healthcare Spending

Figure 6-3: Europe - EQA Scheme Participation by Country (Number), 2010

Figure 9-1: Quest Diagnostics - Sales by Testing (%), 2010

Figure 9-2: Myriad Genetics - Sales by Products (%), 2011

List of Tables:

Table 4-1: Key Companies in DTC Genetic Testing Segment

Table 5-1: Test Availability and Market Size for Key Conditions (2008)

Table 6-1: US - FDA Approved Pharmacogenetic Tests

Table 6-2: EU - Key Indicators in Genetics Market

Table 6-3: Europe - Recognized Accreditation Bodies in Key Countries

Table 8-1: US - Key Elements for Genetic Testing Regulation

Table 8-2: EU - Genetic Testing Regulation in Key Countries

To order this report:

Genomics Industry: Global Genetic Testing Market Analysis

Genomics Business News

More  Company Profile, SWOT and Revenue Analysis!

CONTACT:
Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Thousands Rally in Mexico City and Call for Human Rights Protections in Global AIDS Response
2. Verenium Corporation to Present at Canaccord Adams 28th Annual Global Growth Conference
3. Forward step in forecasting global warming
4. SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE CANACCORD ADAMS 28TH ANNUAL GLOBAL GROWTH CONFERENCE
5. Bionovo to Present at Canaccord Adams Global Growth Conference
6. Pharmasset to Present at the Canaccord Adams Global Growth Conference on Tuesday, August 12th
7. Duff & Phelps Acquires Lumin Expert Group To Build Global Intellectual Property Practice
8. Repair Stem Cell Institute Announces Industrys First Standards of Excellence for Global Stem Cell Treatment Centers to Protect Patients from Less-than-Competent Therapeutics
9. Mindray Medical to Attend Morgan Stanley Global Healthcare Unplugged Conference
10. Oncothyreon announces receipt of notice of non-compliance with market value of listed securities standard for listing on The NASDAQ Global Market
11. 3SBio Inc. to Present at the Morgan Stanley Global Healthcare Unplugged Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 A person commits ... the crime scene to track the criminal down. ... U.S. Food and Drug Administration (FDA) uses DNA evidence to ... Sound far-fetched? It,s not. The FDA has ... to support investigations of foodborne illnesses. Put as simply as ...
(Date:6/23/2016)... Calif. , June 23, 2016  The Prostate Cancer Foundation ... increasingly precise treatments and faster cures for prostate cancer. Members of the Class ... across 15 countries. Read More About the Class of ... ... ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... today announced the launch of the Supplyframe Design Lab . Located in ... to explore the future of how hardware projects are designed, built and brought ...
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
Breaking Biology Technology:
(Date:3/31/2016)... March 31, 2016   ... or the "Company") LegacyXChange is excited to ... its soon to be launched online site for trading ... ) will also provide potential shareholders a sense ... technology to an industry that is notorious for fraud. ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/21/2016)... 2016 Unique technology combines ... superior security   Xura, Inc. ... secure digital communications services, today announced it is working ... enterprise customers, particularly those in the Financial Services Sector, ... authentication within a mobile app, alongside, and in combination ...
Breaking Biology News(10 mins):